{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:09:22Z","timestamp":1793149762397,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"United Arab Emirates University, Zayed Center for Health Sciences","award":["31R135 and 31R259"],"award-info":[{"award-number":["31R135 and 31R259"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Epstein-Barr virus (EBV) is an oncogenic herpesvirus implicated in the pathogenesis of several malignant and non-malignant conditions. However, a number of fundamental aspects about the biology of EBV and the mechanism(s) by which this virus induces pathology remain unknown. One major obstacle has been the lack of a suitable animal model for EBV infection. In this study, using our recently established rabbit model of EBV infection, we examined the early events following primary EBV infection. We show that, both immunocompetent and immunosuppressed animals were readily susceptible to EBV infection. However, immunosuppressed animals showed marked splenomegaly and widespread infection. Following EBV infection\n                    <jats:italic>,<\/jats:italic>\n                    the virus primarily targeted na\u00efve IgM\n                    <jats:sup>+<\/jats:sup>\n                    , CD20\n                    <jats:sup>+<\/jats:sup>\n                    , CD21\n                    <jats:sup>+<\/jats:sup>\n                    and CD79a\n                    <jats:sup>+<\/jats:sup>\n                    B cells. Infected cells expressed varying sets of viral latent\/lytic gene products. Notably, co-expression of latent and lytic proteins in the same cell was not observed. Infected cells in type 0\/1 latency (EBERs\n                    <jats:sup>+<\/jats:sup>\n                    ), were small and proliferating (Ki67\n                    <jats:sup>+<\/jats:sup>\n                    ). By contrast, cells in type 2\/3 latency (LMP1\n                    <jats:sup>+<\/jats:sup>\n                    ), were large, non-proliferating (Ki-67\n                    <jats:sup>\u2212<\/jats:sup>\n                    ) and p53\n                    <jats:sup>+<\/jats:sup>\n                    . Although infected B-cells were widely present in splenic follicles, they did not express germinal center marker, BCL-6. Taken together, this study shows for the first time, some of the early events following primary EBV infection.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-00668-x","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T06:04:13Z","timestamp":1635314653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Uncovering early events in primary Epstein-Barr virus infection using a rabbit model"],"prefix":"10.1038","volume":"11","author":[{"given":"Narendran","family":"Reguraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pretty","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulfaraz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"668_CR1","doi-asserted-by":"publisher","first-page":"43833","DOI":"10.1038\/srep43833","volume":"7","author":"N Omi","year":"2017","unstructured":"Omi, N. et al. Efficient and reliable establishment of lymphoblastoid cell lines by Epstein-Barr virus transformation from a limited amount of peripheral blood. Sci. Rep. 7, 43833 (2017).","journal-title":"Sci. Rep."},{"key":"668_CR2","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1038\/emm.2014.84","volume":"47","author":"M-S Kang","year":"2015","unstructured":"Kang, M.-S. & Kieff, E. Epstein-Barr virus latent genes. Exp. Mol. Med. 47, e131\u2013e131 (2015).","journal-title":"Exp. Mol. Med."},{"key":"668_CR3","doi-asserted-by":"crossref","unstructured":"Hutt-Fletcher, L. M. The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells. J. Virol. 91, (2017).","DOI":"10.1128\/JVI.01677-16"},{"key":"668_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0966-842X(96)90020-7","volume":"4","author":"DA Thorley-Lawson","year":"1996","unstructured":"Thorley-Lawson, D. A., Miyashita, E. M. & Khan, G. Epstein-Barr virus and the B cell: that\u2019s all it takes. Trends Microbiol. 4, 204\u2013208 (1996).","journal-title":"Trends Microbiol."},{"key":"668_CR5","first-page":"549","volume":"33","author":"CM Tsang","year":"2014","unstructured":"Tsang, C. M. et al. Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells. Chin. J. Cancer 33, 549\u2013555 (2014).","journal-title":"Chin. J. Cancer"},{"key":"668_CR6","doi-asserted-by":"publisher","unstructured":"Kimura, H. EBV in T-\/NK-Cell Tumorigenesis. in Human Herpesviruses (eds. Kawaguchi, Y., Mori, Y. & Kimura, H.) 459\u2013475 (Springer, 2018). https:\/\/doi.org\/10.1007\/978-981-10-7230-7_21.","DOI":"10.1007\/978-981-10-7230-7_21"},{"key":"668_CR7","doi-asserted-by":"publisher","first-page":"11139","DOI":"10.1128\/JVI.76.21.11139-11142.2002","volume":"76","author":"P Trempat","year":"2002","unstructured":"Trempat, P. et al. Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus. J. Virol. 76, 11139\u201311142 (2002).","journal-title":"J. Virol."},{"key":"668_CR8","first-page":"1279525","volume":"2017","author":"M Willemsen","year":"2017","unstructured":"Willemsen, M., Dielis, A. W. J. H., Samarska, I. V., Koster, A. & van Marion, A. M. A rare case of angioimmunoblastic T-cell lymphoma with Epstein-Barr virus-negative reed-sternberg-like B-cells, chylous ascites, and chylothorax. Case Rep. Hematol. 2017, 1279525 (2017).","journal-title":"Case Rep. Hematol."},{"key":"668_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","volume":"9","author":"GJ Babcock","year":"1998","unstructured":"Babcock, G. J., Decker, L. L., Volk, M. & Thorley-Lawson, D. A. EBV persistence in memory B cells in vivo. Immunity 9, 395\u2013404 (1998).","journal-title":"Immunity"},{"key":"668_CR10","doi-asserted-by":"publisher","first-page":"e1004656","DOI":"10.1371\/journal.ppat.1004656","volume":"11","author":"AM Price","year":"2015","unstructured":"Price, A. M. & Luftig, M. A. To be or not IIb: A multi-step process for epstein-barr virus latency establishment and consequences for B cell tumorigenesis. PLOS Pathog. 11, e1004656 (2015).","journal-title":"PLOS Pathog."},{"key":"668_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young, L. S., Yap, L. F. & Murray, P. G. Epstein-Barr virus: More than 50 years old and still providing surprises. Nat. Rev. Cancer 16, 789\u2013802 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"668_CR12","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","volume":"81","author":"JD Fingeroth","year":"1984","unstructured":"Fingeroth, J. D. et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81, 4510\u20134514 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"668_CR13","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1073\/pnas.70.9.2487","volume":"70","author":"T Shope","year":"1973","unstructured":"Shope, T., Dechairo, D. & Miller, G. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 70, 2487\u20132491 (1973).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"668_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ijc.2910120202","volume":"12","author":"MA Epstein","year":"1973","unstructured":"Epstein, M. A., Hunt, R. D. & Rabin, H. Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I Reticuloproliferative disease in an inoculated animal. Int. J. Cancer 12, 309\u2013318 (1973).","journal-title":"Int. J. Cancer"},{"key":"668_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/infdis\/150.6.878","volume":"150","author":"N Wedderburn","year":"1984","unstructured":"Wedderburn, N. et al. Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus. J. Infect. Dis. 150, 878\u2013882 (1984).","journal-title":"J. Infect. Dis."},{"key":"668_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.coviro.2015.03.014","volume":"13","author":"C Gujer","year":"2015","unstructured":"Gujer, C. et al. Animal models of Epstein Barr virus infection. Curr. Opin. Virol. 13, 6\u201310 (2015).","journal-title":"Curr. Opin. Virol."},{"key":"668_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jim.2014.04.009","volume":"410","author":"B Chatterjee","year":"2014","unstructured":"Chatterjee, B., Leung, C. S. & M\u00fcnz, C. Animal models of Epstein Barr virus infection. J. Immunol. Methods 410, 80\u201387 (2014).","journal-title":"J. Immunol. Methods"},{"key":"668_CR18","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/emm.2014.88","volume":"47","author":"S Fujiwara","year":"2015","unstructured":"Fujiwara, S., Imadome, K.-I. & Takei, M. Modeling EBV infection and pathogenesis in new-generation humanized mice. Exp. Mol. Med. 47, e135\u2013e135 (2015).","journal-title":"Exp. Mol. Med."},{"key":"668_CR19","first-page":"407","volume":"391","author":"C M\u00fcnz","year":"2015","unstructured":"M\u00fcnz, C. EBV infection of mice with reconstituted human immune system components. Curr. Top. Microbiol. Immunol. 391, 407\u2013423 (2015).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"668_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12985-017-0859-5","volume":"14","author":"Z Wang","year":"2017","unstructured":"Wang, Z. et al. A study of Epstein-Barr virus infection in the Chinese tree shrew (Tupaia belangeri chinensis). Virol. J. 14, 193 (2017).","journal-title":"Virol. J."},{"issue":"Suppl 2","key":"668_CR21","doi-asserted-by":"publisher","first-page":"B194","DOI":"10.1016\/j.vaccine.2012.09.041","volume":"31","author":"JI Cohen","year":"2013","unstructured":"Cohen, J. I., Mocarski, E. S., Raab-Traub, N., Corey, L. & Nabel, G. J. The need and challenges for development of an Epstein-Barr virus vaccine. Vaccine 31(Suppl 2), B194-196 (2013).","journal-title":"Vaccine"},{"key":"668_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jmv.21597","volume":"82","author":"K Okuno","year":"2010","unstructured":"Okuno, K. et al. Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humans. J. Med. Virol. 82, 977\u2013986 (2010).","journal-title":"J. Med. Virol."},{"key":"668_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.virusres.2010.07.026","volume":"153","author":"K Kanai","year":"2010","unstructured":"Kanai, K. et al. Lifelong persistent EBV infection of rabbits with EBER1-positive lymphocyte infiltration and mild sublethal hemophagocytosis. Virus Res. 153, 172\u2013178 (2010).","journal-title":"Virus Res."},{"key":"668_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12985-015-0260-1","volume":"12","author":"G Khan","year":"2015","unstructured":"Khan, G., Ahmed, W., Philip, P. S., Ali, M. H. & Adem, A. Healthy rabbits are susceptible to Epstein-Barr virus infection and infected cells proliferate in immunosuppressed animals. Virol. J. 12, 28 (2015).","journal-title":"Virol. J."},{"key":"668_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.30802\/AALAS-CM-20-000019","volume":"70","author":"AJ Osborne","year":"2020","unstructured":"Osborne, A. J. et al. Antibody-mediated immune subset depletion modulates the immune response in a rabbit (oryctolagus cuniculus) model of Epstein-Barr virus infection. Comp. Med. 70, 312\u2013322 (2020).","journal-title":"Comp. Med."},{"key":"668_CR26","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1073\/pnas.2627966100","volume":"100","author":"J Kurth","year":"2003","unstructured":"Kurth, J., Hansmann, M.-L., Rajewsky, K. & K\u00fcppers, R. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc. Natl. Acad. Sci. U. S. A. 100, 4730\u20134735 (2003).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"668_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.exphem.2006.02.021","volume":"34","author":"G Khan","year":"2006","unstructured":"Khan, G. Epstein-Barr virus and the germinal center B cells. Exp. Hematol. 34, 695\u2013696 (2006).","journal-title":"Exp. Hematol."},{"key":"668_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<326::AID-PATH242>3.0.CO;2-N","volume":"187","author":"I Araujo","year":"1999","unstructured":"Araujo, I. et al. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J. Pathol. 187, 326\u2013330 (1999).","journal-title":"J. Pathol."},{"key":"668_CR29","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1182\/blood-2008-08-175828","volume":"113","author":"S Chaganti","year":"2009","unstructured":"Chaganti, S. et al. Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence. Blood 113, 6372\u20136381 (2009).","journal-title":"Blood"},{"key":"668_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1074-7613(00)80493-8","volume":"5","author":"G Khan","year":"1996","unstructured":"Khan, G., Miyashita, E. M., Yang, B., Babcock, G. J. & Thorley-Lawson, D. A. Is EBV persistence in vivo a model for B cell homeostasis?. Immunity 5, 173\u2013179 (1996).","journal-title":"Immunity"},{"key":"668_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.190.4.567","volume":"190","author":"GJ Babcock","year":"1999","unstructured":"Babcock, G. J., Decker, L. L., Freeman, R. B. & Thorley-Lawson, D. A. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J. Exp. Med. 190, 567\u2013576 (1999).","journal-title":"J. Exp. Med."},{"key":"668_CR32","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","volume":"22","author":"LS Young","year":"2003","unstructured":"Young, L. S. & Murray, P. G. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22, 5108\u20135121 (2003).","journal-title":"Oncogene"},{"key":"668_CR33","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","volume":"321","author":"L Young","year":"1989","unstructured":"Young, L. et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321, 1080\u20131085 (1989).","journal-title":"N. Engl. J. Med."},{"key":"668_CR34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","volume":"378","author":"D Dierickx","year":"2018","unstructured":"Dierickx, D. & Habermann, T. M. Post-transplantation lymphoproliferative disorders in adults. N. Engl. J. Med. 378, 549\u2013562 (2018).","journal-title":"N. Engl. J. Med."},{"key":"668_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jmv.21102","volume":"80","author":"K Takashima","year":"2008","unstructured":"Takashima, K. et al. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis. J. Med. Virol. 80, 455\u2013466 (2008).","journal-title":"J. Med. Virol."},{"key":"668_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000360223","volume":"57","author":"J Raj\u010d\u00e1ni","year":"2014","unstructured":"Raj\u010d\u00e1ni, J. et al. Epstein-Barr Virus (HHV-4) inoculation to rabbits by intranasal and oral routes results in subacute and\/or persistent infection dissimilar to human disease. Intervirology 57, 254\u2013269 (2014).","journal-title":"Intervirology"},{"issue":"Suppl 1","key":"668_CR37","first-page":"S109","volume":"2","author":"E Tatsumi","year":"1986","unstructured":"Tatsumi, E. & Purtilo, D. T. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP). AIDS Res. 2(Suppl 1), S109-113 (1986).","journal-title":"AIDS Res."},{"key":"668_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/2424","volume":"20","author":"AJ Coffey","year":"1998","unstructured":"Coffey, A. J. et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20, 129\u2013135 (1998).","journal-title":"Nat. Genet."},{"key":"668_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/26683","volume":"395","author":"J Sayos","year":"1998","unstructured":"Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462\u2013469 (1998).","journal-title":"Nature"},{"key":"668_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fimmu.2019.00146","volume":"10","author":"MHM Barros","year":"2019","unstructured":"Barros, M. H. M., Vera-Lozada, G., Segges, P., Hassan, R. & Niedobitek, G. Revisiting the tissue microenvironment of infectious mononucleosis: Identification of EBV infection in T cells and deep characterization of immune profiles. Front. Immunol. 10, 146 (2019).","journal-title":"Front. Immunol."},{"key":"668_CR41","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1128\/JVI.00108-09","volume":"83","author":"C Shannon-Lowe","year":"2009","unstructured":"Shannon-Lowe, C. et al. Features distinguishing Epstein-Barr virus infections of epithelial cells and b cells: Viral genome expression, genome maintenance, and genome amplification. J. Virol. 83, 7749 (2009).","journal-title":"J. Virol."},{"key":"668_CR42","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1128\/JVI.77.8.5000-5007.2003","volume":"77","author":"S Prince","year":"2003","unstructured":"Prince, S. et al. Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms. J. Virol. 77, 5000 (2003).","journal-title":"J. Virol."},{"key":"668_CR43","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1006\/viro.1996.8352","volume":"227","author":"S Wen","year":"1997","unstructured":"Wen, S., Mizugaki, Y., Shinozaki, F. & Takada, K. Epstein-Barr virus (EBV) Infection in salivary gland tumors: Lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells. Virology 227, 484\u2013487 (1997).","journal-title":"Virology"},{"key":"668_CR44","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1128\/JVI.72.11.9323-9328.1998","volume":"72","author":"N Greifenegger","year":"1998","unstructured":"Greifenegger, N., J\u00e4ger, M., Kunz-Schughart, L. A., Wolf, H. & Schwarzmann, F. Epstein-Barr virus small RNA (EBER) genes: differential regulation during lytic viral replication. J. Virol. 72, 9323\u20139328 (1998).","journal-title":"J. Virol."},{"key":"668_CR45","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1182\/blood-2014-08-594176","volume":"125","author":"V Lajoie","year":"2015","unstructured":"Lajoie, V. et al. LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates. Blood 125, 2101\u20132110 (2015).","journal-title":"Blood"},{"key":"668_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0046-8177(97)90040-X","volume":"28","author":"R Chetty","year":"1997","unstructured":"Chetty, R., Biddolph, S. & Gatter, K. An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: The possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin\u2019s disease and Reed-Sternberg-like cells in non-Hodgkin\u2019s lymphomas and reactive conditions. Hum. Pathol. 28, 493\u2013498 (1997).","journal-title":"Hum. Pathol."},{"key":"668_CR47","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ijc.2910380618","volume":"38","author":"MC Favrot","year":"1986","unstructured":"Favrot, M. C. et al. EBV-negative and -positive Burkitt cell lines variably express receptors for B-cell activation and differentiation. Int. J. Cancer 38, 901\u2013906 (1986).","journal-title":"Int. J. Cancer"},{"key":"668_CR48","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1128\/JVI.76.20.10427-10436.2002","volume":"76","author":"KL Carter","year":"2002","unstructured":"Carter, K. L., Cahir-McFarland, E. & Kieff, E. Epstein-Barr virus-induced changes in B-lymphocyte gene expression. J. Virol. 76, 10427\u201310436 (2002).","journal-title":"J. Virol."},{"key":"668_CR49","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1128\/JVI.79.12.7355-7362.2005","volume":"79","author":"MA Swanson-Mungerson","year":"2005","unstructured":"Swanson-Mungerson, M. A., Caldwell, R. G., Bultema, R. & Longnecker, R. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion Response to Autoantigen. J. Virol. 79, 7355\u20137362 (2005).","journal-title":"J. Virol."},{"key":"668_CR50","doi-asserted-by":"publisher","first-page":"16046","DOI":"10.1073\/pnas.1901314116","volume":"116","author":"P Mrozek-Gorska","year":"2019","unstructured":"Mrozek-Gorska, P. et al. Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. Proc. Natl. Acad. Sci. 116, 16046\u201316055 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"668_CR51","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1128\/JVI.02609-08","volume":"83","author":"JE Roughan","year":"2009","unstructured":"Roughan, J. E. & Thorley-Lawson, D. A. The intersection of Epstein-Barr virus with the germinal center. J. Virol. 83, 3968\u20133976 (2009).","journal-title":"J. Virol."},{"key":"668_CR52","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1128\/jvi.70.12.8653-8659.1996","volume":"70","author":"KL Fries","year":"1996","unstructured":"Fries, K. L., Miller, W. E. & Raab-Traub, N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70, 8653\u20138659 (1996).","journal-title":"J. Virol."},{"key":"668_CR53","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/leu.2009.92","volume":"23","author":"B Renouf","year":"2009","unstructured":"Renouf, B. et al. Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt\u2019s lymphoma cells. Leukemia 23, 1557\u20131563 (2009).","journal-title":"Leukemia"},{"key":"668_CR54","first-page":"1027","volume":"11","author":"I Okan","year":"1995","unstructured":"Okan, I. et al. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 11, 1027\u20131031 (1995).","journal-title":"Oncogene"},{"key":"668_CR55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S1525-1578(10)60535-1","volume":"6","author":"JL Ryan","year":"2004","unstructured":"Ryan, J. L. et al. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: A novel approach to screen for the virus in paraffin-embedded tissue and plasma. J. Mol. Diagn. 6, 378\u2013385 (2004).","journal-title":"J. Mol. Diagn."},{"key":"668_CR56","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S1525-1578(10)60535-1","volume":"6","author":"JL Ryan","year":"2004","unstructured":"Ryan, J. L. et al. Epstein-Barr virus quantitation by real-time pcr targeting multiple gene segments. J. Mol. Diagn. JMD 6, 378\u2013385 (2004).","journal-title":"J. Mol. Diagn. JMD"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00668-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:57:43Z","timestamp":1670068663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00668-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00668-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-741952\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21220"}}